Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
59.32
-1.76 (-2.88%)
Nov 17, 2026, 4:00 PM EST

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
27,59426,56417,23719,53016,03014,959
Market Cap Growth
-8.30%54.11%-11.74%21.83%7.16%-
Enterprise Value
23,29525,70417,34218,89114,51814,805
Last Close Price
59.3257.6041.4747.8539.3737.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.5433.1647.89213.94-1454.37
PB Ratio
5.5420.5086.1623.019.126.07
P/TBV Ratio
5.9829.60-50.5112.667.53

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.6732.0848.18206.94-1439.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.260.965.790.480.050.04
Debt / FCF Ratio
0.38-----
Net Debt / Equity Ratio
-0.86-0.541.59-0.40-0.76-0.81
Net Debt / EBITDA Ratio
-1.250.90-0.340.301.773.12
Net Debt / FCF Ratio
-1.260.92-0.400.341.973.97
Asset Turnover
1.040.340.220.05-0.01
Inventory Turnover
0.960.840.280.54--
Quick Ratio
6.522.111.111.785.709.82
Current Ratio
6.662.221.272.035.939.96
Return on Equity (ROE)
107.35%-102.76%-179.21%-84.98%-34.87%-37.83%
Return on Assets (ROA)
44.34%-21.71%-37.81%-40.35%-20.52%-21.46%
Return on Capital Employed (ROCE)
59.10%-40.60%-104.20%-110.20%-43.20%-26.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
12.50%-2.88%-4.91%-5.67%-4.59%-4.48%
FCF Yield
12.38%-2.86%-4.57%-5.12%-4.22%-3.35%
Buyback Yield / Dilution
-7.35%-7.75%-1.83%-0.70%-12.29%-0.07%